Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus

Citations Over TimeTop 1% of 2010 papers

Abstract

Saxagliptin added to metformin therapy was effective in improving glycaemic control in patients with type 2 diabetes mellitus inadequately controlled by metformin alone; saxagliptin plus metformin was noninferior to sitagliptin plus metformin, and was generally well tolerated.

Related Papers

• → No increased risk of hospitalization for heart failure for patients treated with dipeptidyl peptidase-4 inhibitors in Taiwan(2016)28 cited
• → Efficacy and short-term side effects of sitagliptin, vildagliptin and saxagliptin in Chinese diabetes: a randomized clinical trial(2019)16 cited
• → Dynamics of switching, adherence, and persistence of dipeptidyl peptidase-4 inhibitors use: A nationwide cohort study(2019)1 cited
• Dipeptidyl-peptidase IV inhibitors for treatment of type 2 diabetes mellitus:an overview of systematic reviews(2013)
• → Abstract 14879: Comparing the Risk of Heart Failure Among Different Dipeptidyl Peptidase 4 Inhibitors(2015)